Pharmacotherapy of Patients With Borderline Personality Disorder
Abstract
Although it is clear from research studies that some patients with borderline personality disorder improve following pharmacological treatment, their response to drugs may be unpredictable. Neuroleptics and carbamazepine may reduce impulsivity in some patients, but other patients may become melancholically depressed. Alprazolam and tricyclic antidepressants may improve mood, but some patients may also become disinhibited, suicidal, and violent. Therefore, any medication trial should be conducted with careful attention to paradoxical effects.
In our work, medications are a very valuable tool. They can often help patients attain a much greater level of functioning, diminish family crises, enable therapy to progress more smoothly, and may reduce the need for hospitalization or emergency interventions.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
